Thomas W. Ross Sr. - 19 May 2023 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Reporting relationship: Director
Issuer ticker: BHC
Reported as of: 19 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 May 2023, 16:24:30 UTC
Prior SEC filing: 05 May 2023
Next SEC filing: 06 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Brianna M. Cetrulo, attorney-in-fact

Key filing fact

Thomas W. Ross Sr. filed Form 4 for Bausch Health Companies Inc. (BHC) on 19 May 2023.

Key facts

This page summarizes Thomas W. Ross Sr.'s Form 4 filing for Bausch Health Companies Inc. (BHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2023, 16:24.

Change

Previous filing in this sequence was filed on 05 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHC transaction

Common Shares, No Par Value

Award

Transaction value: $0
Shares: +29,205
Change %: +22%
Price: $0.000000
Shares after: 161,516
Date: 19 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.